The bioneemtec India Private limited , was established in the year 2013. Our main vision is to be the most credible incubation centre for institutions and industries. We are striving hard with a mission to develop a unique laboratory for Analytical, Biotechnology, Natural products and Synthetic chemistry, created to bring together an alliance of academia, government, and the industries to integrate research, development, and commercialization of potentially useful natural products from plants, microbes, algae, sponges etc..
AN UNIQUE PLACE FOR ACTIVE MOLECULES ...
Chennai-based incubation Centre for research, Bioneemtec India, has joined the effort to developing a compound to control the replication of Coronavirus in the body and eliminate Covid-19. The start-up has been working on developing molecules that have anti-HIV properties. As Covid-19 has similar activity, teh firm has started developing molecules targeting the disease as well. The company has been conducting computer-based molecular docking tests and is planning to carry them out in a laboratory in the US, through an agreement. The company has designed the molecule and has filed for a patent in India."Data from the preliminary study shows that the compound is active against Covid-19. We have filed for the patent and now we are looking for funding to take the research forward. We have to develop around 30-50 compounds and screen through wet lab analyses to take it forward," said Dr.M.Menaga ,Director of Bioneemtec India Pvt Ltd. Bioneemtec.
Our Mission is to accelerate the launch of New Drugs through our continuous Technological Innovations and provoiding High quality Sigle step- Research and development ,Production and Contract Manufacturing Services for the full services of Drug development for Pharmaceutical and Biotechnological companies Globally .